Perspective Therapeutics, Inc.
CATX· NYSE
CATXPerspective Therapeutics, Inc.
Filed May 15, 2013 · 10-Q · 45 days after period end · 0001144204-13-028975
| Metric | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|
| Revenue | $1.25M | $1.32M | $1.41M |
| Net Income | -$715.04K | -$552.89K | -$1.03M |
| EPS Diluted | -$0.02 | -$0.02 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Perspective Therapeutics, Inc. · CIK 728387 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end
